Protective effects of a novel probiotic strain, Lactococcus lactis ML2018, in colitis: in vivo and in vitro evidence-Reference-Cited by-同舟云学术

Protective effects of a novel probiotic strain, Lactococcus lactis ML2018, in colitis: in vivo and in vitro evidence

Published:2019 Issue:2 Volume:10 Page:1132-1145
ISSN:2042-6496
Container-title:Food & Function
language:en
Short-container-title:Food Funct.

Author:

Liu Meiling¹²³⁴⁵,Zhang Xiuxia¹²³⁴⁵,Hao Yunpeng¹²³⁴⁵,Ding Jinhua¹²³⁴⁵,Shen Jing¹²³⁴⁵,Xue Ziyu¹²³⁴⁵,Qi Wei¹²³⁴⁵,Li Zhongyuan¹²³⁴⁵,Song Yajian¹²³⁴⁵,Zhang Tongcun¹²³⁴⁵,Wang Nan¹²³⁴⁵^ORCID

Affiliation:

1. Key Laboratory of Industrial Fermentation Microbiology

2. Ministry of Education and Tianjin

3. College of Biotechnology

4. Tianjin University of Science and Technology

5. P.R. China

Abstract

Multiple articles have confirmed that an imbalance of the intestinal microbiota is closely related to aberrant immune responses of the intestines and to the pathogenesis of inflammatory bowel diseases (IBDs).

Funder

Natural Science Foundation of Tianjin City

Publisher

Royal Society of Chemistry (RSC)

Subject

General Medicine,Food Science

Link

http://pubs.rsc.org/en/content/articlepdf/2019/FO/C8FO02301H

Reference61 articles.

1. Understanding inflammatory bowel disease via immunogenetics

2. Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn's disease: a randomised, double blind, placebo controlled GETAID trial

3. Drug Insight: aminosalicylates for the treatment of IBD